Literature DB >> 3096039

Why do children with diabetes die?

J Scibilia, D Finegold, J Dorman, D Becker, A Drash.   

Abstract

While the treatment of children with Type I diabetes mellitus has dramatically improved since the introduction of insulin in 1922, significant acute mortality still remains. To better ascertain the causes of death in younger children and adolescents with diabetes mellitus, a retrospective review was undertaken of diabetes associated mortality in the patient population followed at the Children's Hospital of Pittsburgh between the years 1950 and 1985. Fifty-five deaths were identified of which 20 occurred during the initial presentation of diabetes and 35 occurred between 2 months and 11 years following the diagnosis of diabetes mellitus. Diabetic ketoacidosis (DKA) was associated with 64% of the total mortality with 85% of the early onset and 54% of the late onset deaths being ketoacidosis related. Of these ketoacidosis associated deaths, cerebral edema was documented in 31%, or 20% of the total group mortality. Non ketoacidosis deaths in both early and late onset groups were caused by heterogeneous events. There were no deaths associated with the traditional late vascular complications of diabetes mellitus. Since diabetic ketoacidosis is a potentially preventable acute complication of diabetes mellitus and represented a predominant cause of mortality in these children, early recognition and prompt treatment might substantially reduce childhood mortality in patients with Type I diabetes mellitus.

Entities:  

Mesh:

Year:  1986        PMID: 3096039     DOI: 10.1530/acta.0.112s326

Source DB:  PubMed          Journal:  Acta Endocrinol Suppl (Copenh)        ISSN: 0300-9750


  20 in total

Review 1.  Cerebral oedema in childhood diabetic ketoacidosis: is treatment a factor?

Authors:  T B Brown
Journal:  Emerg Med J       Date:  2004-03       Impact factor: 2.740

Review 2.  Management of diabetic ketoacidosis.

Authors:  Neil H White
Journal:  Rev Endocr Metab Disord       Date:  2003-12       Impact factor: 6.514

3.  Can regional variation in "avoidable" mortality be explained by deaths outside hospital? A study from Sweden, 1987-90.

Authors:  R Westerling
Journal:  J Epidemiol Community Health       Date:  1996-06       Impact factor: 3.710

4.  Causes of death in children with insulin dependent diabetes 1990-96.

Authors:  J A Edge; M E Ford-Adams; D B Dunger
Journal:  Arch Dis Child       Date:  1999-10       Impact factor: 3.791

Review 5.  [Diabetic coma. Management of diabetic ketoacidosis and nonketotic hyperosmolar coma].

Authors:  J Hensen
Journal:  Internist (Berl)       Date:  2003-10       Impact factor: 0.743

6.  Pediatric diabetic ketoacidosis, fluid therapy, and cerebral injury: the design of a factorial randomized controlled trial.

Authors:  Nicole S Glaser; Simona Ghetti; T Charles Casper; J Michael Dean; Nathan Kuppermann
Journal:  Pediatr Diabetes       Date:  2013-03-13       Impact factor: 4.866

Review 7.  Cerebral edema in children with diabetic ketoacidosis.

Authors:  N Glaser
Journal:  Curr Diab Rep       Date:  2001-08       Impact factor: 4.810

8.  Clinical Trial of Fluid Infusion Rates for Pediatric Diabetic Ketoacidosis.

Authors:  Nathan Kuppermann; Simona Ghetti; Jeff E Schunk; Michael J Stoner; Arleta Rewers; Julie K McManemy; Sage R Myers; Lise E Nigrovic; Aris Garro; Kathleen M Brown; Kimberly S Quayle; Jennifer L Trainor; Leah Tzimenatos; Jonathan E Bennett; Andrew D DePiero; Maria Y Kwok; Clinton S Perry; Cody S Olsen; T Charles Casper; J Michael Dean; Nicole S Glaser
Journal:  N Engl J Med       Date:  2018-06-14       Impact factor: 91.245

9.  Improvements in the life expectancy of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications study cohort.

Authors:  Rachel G Miller; Aaron M Secrest; Ravi K Sharma; Thomas J Songer; Trevor J Orchard
Journal:  Diabetes       Date:  2012-07-30       Impact factor: 9.461

10.  Assessment of psychosocial variables by parents of youth with type 1 diabetes mellitus.

Authors:  Fani Eta Korn Malerbi; Carlos Antonio Negrato; Marilia B Gomes
Journal:  Diabetol Metab Syndr       Date:  2012-11-22       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.